|
June
Monday, Jun 23, 2008 Genentech Announces July 14 Webcast of Financial and Other Business Results Wednesday, Jun 11, 2008 Genentech Settles Dispute Related To Cabilly Patent May Saturday, May 31, 2008 Second Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in Women With Advanced HER2-Negative Breast Cancer Monday, May 19, 2008 Genentech Announces June 2 Webcast Discussion of Data Presented at ASCO Thursday, May 15, 2008 Genentech Provides Update on Avastin Program Thursday, May 15, 2008 Genentech Provides Update On Studies Of Investigational Biooncology Agents To Be Presented At The American Society Of Clinical Oncology Meeting April Tuesday, Apr 29, 2008 Genentech and Biogen Idec Announce Top-Line Results From Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus Thursday, Apr 24, 2008 Genentech Announces Decision In Contract Dispute Sunday, Apr 20, 2008 Genentech Provides Update on "AVAiL" Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer Tuesday, Apr 15, 2008 Genentech Extends Stock Repurchase Program Monday, Apr 14, 2008 Genentech and Biogen Idec Announce Top-Line Results from a Phase II/III Clinical Trial of Rituxan in Primary-Progressive Multiple Sclerosis Thursday, Apr 10, 2008 Genentech Announces First Quarter 2008 Results See the Archives 
 |
